Yongzhan Sun

Jiangsu Key Laboratory Of New Drug Research And Clinical Pharmacy, 209 Tongshan Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: November 29, 2025

Targeting USP28 inhibits clear cell renal cell carcinoma growth.

Targeting USP28 inhibits clear cell renal cell carcinoma growth.

Journal: Cellular signalling

Published: August 15, 2025

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD.

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD.

Journal: Archives of pharmacal research

Published: May 22, 2025

Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease.

Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease.

Journal: Biochemical pharmacology

Published: February 12, 2025

Enhancer Profiling Reveals a Protective Role of RXRα Against Calcium Oxalate-Induced Crystal Deposition and Kidney Injury.

Enhancer Profiling Reveals a Protective Role of RXRα Against Calcium Oxalate-Induced Crystal Deposition and Kidney Injury.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 23, 2024

Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB.

Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB.

Journal: EMBO molecular medicine

Published: July 12, 2024

Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease.

Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: April 01, 2022

Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 20, 2021

White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism.

White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism.

Journal: Gene

Published: October 22, 2021

cAMP-Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

cAMP-Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 15, 2021

Integrative Cistromic and Transcriptomic Analyses Identify CREB Target Genes in Cystic Renal Epithelial Cells.

Integrative Cistromic and Transcriptomic Analyses Identify CREB Target Genes in Cystic Renal Epithelial Cells.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 26, 2021

HRP2-DPF3a-BAF complex coordinates histone modification and chromatin remodeling to regulate myogenic gene transcription.

HRP2-DPF3a-BAF complex coordinates histone modification and chromatin remodeling to regulate myogenic gene transcription.

Journal: Nucleic acids research

Published: April 10, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026